Harmony Biosciences director granted 21,872 stock options
Harmony Biosciences Holdings, Inc. director Juan A. Sabater received a grant of stock options as part of his compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. director Juan A. Sabater received a grant of stock options as part of his compensation. He was awarded options for 21,872 shares of common stock at an exercise price of $30.76 per share, giving him the right to buy shares at that price in the future. These options vest in full on the earlier of May 14, 2027 or the date of the next annual meeting after the grant, as long as he continues to serve through that vesting date. After this grant, he holds 21,872 stock options directly.
Insider Trade Summary
Grant/Award: 21,872 shares
Grant/Award
1 txn
Insider
Sabater Juan A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 21,872 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 21,872 contracts (Direct)
Footnotes (1)
- F1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
Options granted: 21,872 options
Exercise price: $30.76 per share
Underlying shares: 21,872 shares
+2 more
5 metrics
Options granted
21,872 options
Stock option award to director Juan A. Sabater
Exercise price
$30.76 per share
Strike price for Harmony Biosciences stock options
Underlying shares
21,872 shares
Common stock underlying granted options
Expiration date
May 14, 2036
Option expiration for director award
Post-grant option holdings
21,872 options
Total options held after reported transaction
Key Terms
Stock Option, exercise price, expiration date, vest in full, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "30.7600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-05-14T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest in full financial
"The stock option shall vest in full on the earlier to occur of"
annual meeting financial
"the date of the next annual meeting following the grant date"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Harmony Biosciences (HRMY) director Juan A. Sabater receive in this Form 4?
Director Juan A. Sabater received a grant of stock options for 21,872 shares at an exercise price of $30.76 per share. This is a compensation-related award, not an open-market purchase or sale, and gives him the right to buy Harmony Biosciences common stock in the future.
Is the Harmony Biosciences (HRMY) Form 4 transaction a stock buy or sell?
The Form 4 shows an acquisition through a stock option grant, not a buy or sell in the market. The transaction is coded as an award (code A), meaning options were granted as compensation rather than purchased or sold on an exchange.
What are the terms of Juan A. Sabater’s Harmony Biosciences (HRMY) stock options?
Sabater’s stock options cover 21,872 underlying common shares at a $30.76 exercise price and expire on May 14, 2036. The options vest in full on the earlier of May 14, 2027 or the next annual meeting date, subject to his continued service.
When do the Harmony Biosciences (HRMY) options granted to Juan A. Sabater vest?
The options vest in full on the earlier of May 14, 2027 or the date of the next annual meeting following the grant. Vesting depends on Sabater continuing to serve through the applicable vesting date, aligning the award with his ongoing board service.
How many Harmony Biosciences (HRMY) derivative securities does Juan A. Sabater hold after this Form 4?
Following this grant, Sabater holds 21,872 stock options directly, each tied to one share of Harmony Biosciences common stock. This total reflects the options reported in the filing and represents his derivative holdings from this specific compensation award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates